Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	4.49B -46.0%
Revenue (ttm)	1.51B -36.1%
Net Income	283.50M -49.2%
EPS	1.21 -49.3%
Shares Out	234.33M
PE Ratio	15.88
Forward PE	n/a
Dividend	2.50 (13.03%)
Ex-Dividend Date	Jul 1, 2026

Volume	2,527,236
Open	19.61
Previous Close	19.61
Day's Range	19.14 - 19.61
52-Week Range	18.41 - 36.16
Beta	0.13
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, glycyrrhizin zinc granules, compound calcium carbonate, vitamin AD drops, iprastat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salts, montmorillonite powder, azithromycin granules, rifaximin dry suspension, and dimercaptosuccinic acid capsules. In addition, it offers informati...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,719
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2025, Shandong Wit Dyne Health's revenue was 2.23 billion, an increase of 4.40% compared to the previous year's 2.13 billion. Earnings were 535.08 million, an increase of 3.78%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error